| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
1998-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c9f5c9df2566ab78f74aff5ff0f303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3ca87716da3763df9ce1cb843eeb129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1da69eb25d2180d95cc1049c84cb6a6 |
| publicationDate |
1999-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11228397-A |
| titleOfInvention |
Topical corneal disease treatment |
| abstract |
(57) [Summary] The present invention provides a therapeutic agent for corneal diseases which promotes migration, extension and proliferation of corneal epithelial cells at the time of wounding and positively promotes corneal epithelial coating. SOLUTION: The therapeutic agent for corneal diseases containing catecholamine or a salt thereof as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115177729-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006282586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006151828-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007063218-A |
| priorityDate |
1998-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |